Hameed, Olsen, Cheng et al.: "Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody." in: The American journal of pathology, Vol. 140, Issue 5, pp. 1025-30, 1992 (PubMed).
Lichtenheld, Olsen, Lu et al.: "Structure and function of human perforin." in: Nature, Vol. 335, Issue 6189, pp. 448-51, 1988 (PubMed).
Masson, Tschopp: "Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes." in: The Journal of biological chemistry, Vol. 260, Issue 16, pp. 9069-72, 1985 (PubMed).
Lowin, Hahne, Mattmann et al.: "Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways." in: Nature, Vol. 370, Issue 6491, pp. 650-2, 1994 (PubMed).
Braun, Lowin, French et al.: "Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease." in: The Journal of experimental medicine, Vol. 183, Issue 2, pp. 657-61, 1996 (PubMed).
Smyth, Thia, Cretney et al.: "Perforin is a major contributor to NK cell control of tumor metastasis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 162, Issue 11, pp. 6658-62, 1999 (PubMed).
Rode, Balkow, Sobek et al.: "Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection." in: Journal of virology, Vol. 78, Issue 22, pp. 12395-405, 2004 (PubMed).
Gupta, Greer, Mahanty et al.: "CD8-mediated protection against Ebola virus infection is perforin dependent." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 7, pp. 4198-202, 2005 (PubMed).